Zinc Signaling in the Mammary Gland: For Better and for Worse
Abstract
:1. Zinc, an Essential Micronutrient
2. Zn2+ as a Signaling Molecule
3. Zn2+ and Its Transporters in the Physiology of Mammary Gland
4. Zn2+ Homeostasis and Zn2+ Transporters in Breast Cancer
5. ZnT Family and Breast Cancer
ZnT2
6. ZIP Family and Breast Cancer
6.1. ZIP6
6.2. ZIP7
6.3. ZIP10
7. The Zinc Sensing Receptor ZnR/GPR39 and Cancer
8. Emerging Targets for Breast Cancer Treatment
9. Summary and Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Gibson, R.S.; King, J.C.; Lowe, N. A Review of Dietary Zinc Recommendations. Food Nutr. Bull. 2016, 37, 443–460. [Google Scholar] [CrossRef] [Green Version]
- Sandstead, H.H.; Freeland-Graves, J.H. Dietary phytate, zinc and hidden zinc deficiency. J. Trace Elem. Med. Biol. 2014, 28, 414–417. [Google Scholar] [CrossRef]
- King, J.C.; Brown, K.H.; Gibson, R.S.; Krebs, N.F.; Lowe, N.M.; Siekmann, J.H.; Raiten, D.J. Biomarkers of Nutrition for Development (BOND)-Zinc Review. J. Nutr. 2015, 146, 858S–885S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wessells, K.R.; Brown, K.H. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS ONE 2012, 7, e50568. [Google Scholar] [CrossRef] [Green Version]
- Hesse, S. Zinc Deficiency. In Nutrition and Health in a Developing World, 3rd ed.; de Pee, S., Taren, D., Bloem, M., Eds.; Humana Press: Cham, Switzerland, 2017; pp. 265–285. [Google Scholar]
- Prasad, A.S. Discovery of human zinc deficiency: 50 years later. J. Trace Elem. Med. Biol. 2012, 26, 66–69. [Google Scholar] [CrossRef]
- Prasad, A.S. Clinical manifestations of zinc deficiency. Annu. Rev. Nutr. 1985, 5, 341–363. [Google Scholar] [CrossRef]
- Dufner-Beattie, J.; Weaver, B.P.; Geiser, J.; Bilgen, M.; Larson, M.; Xu, W.; Andrews, G.K. The mouse acrodermatitis enteropathica gene Slc39a4 (Zip4) is essential for early development and heterozygosity causes hypersensitivity to zinc deficiency. Hum. Mol. Genet. 2007, 16, 1391–1399. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neldner, K.H.; Hambidge, K.M.; Walravens, P.A. Acrodermatitis enteropathica. Int. J. Derm. 1978, 17, 380–387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neldner, K.H.; Hambidge, K.M. Zinc therapy of acrodermatitis enteropathica. N. Engl. J. Med. 1975, 292, 879–882. [Google Scholar] [CrossRef] [PubMed]
- Brown, K.H.; Peerson, J.M.; Rivera, J.; Allen, L.H. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2002, 75, 1062–1071. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ackland, M.L.; Michalczyk, A.A. Zinc and infant nutrition. Arch. Biochem. Biophys. 2016, 611, 51–57. [Google Scholar] [CrossRef] [PubMed]
- Prasad, A.S. Zinc deficiency. Bmj 2003, 326, 409–410. [Google Scholar] [CrossRef]
- Krebs, N.F.; Hambidge, K.M. Zinc requirements and zinc intakes of breast-fed infants. Am. J. Clin. Nutr. 1986, 43, 288–292. [Google Scholar] [CrossRef]
- Murphy, J.F.; Gray, O.P.; Rendall, J.R.; Hann, S. Zinc deficiency: A problem with preterm breast milk. Early. Hum. Dev. 1985, 10, 303–307. [Google Scholar] [CrossRef]
- Kuramoto, Y.; Igarashi, Y.; Tagami, H. Acquired zinc deficiency in breast-fed infants. Semin. Derm. 1991, 10, 309–312. [Google Scholar]
- Lasry, I.; Seo, Y.A.; Ityel, H.; Shalva, N.; Pode-Shakked, B.; Glaser, F.; Berman, B.; Berezovsky, I.; Goncearenco, A.; Klar, A.; et al. A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency. J. Biol. Chem. 2012, 287, 29348–29361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zimmerman, A.W.; Hambidge, K.M.; Lepow, M.L.; Greenberg, R.D.; Stover, M.L.; Casey, C.E. Acrodermatitis in breast-fed premature infants: Evidence for a defect of mammary zinc secretion. Pediatrics 1982, 69, 176–183. [Google Scholar]
- Prasad, A.S. Zinc deficiency in human subjects. Prog. Clin. Biol. Res. 1983, 129, 1–33. [Google Scholar] [PubMed]
- Leone, N.; Courbon, D.; Ducimetiere, P.; Zureik, M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 2006, 17, 308–314. [Google Scholar] [CrossRef]
- Levenson, C.W.; Somers, R.C. Nutritionally regulated biomarkers for breast cancer. Nutr. Rev. 2008, 66, 163–166. [Google Scholar] [CrossRef] [PubMed]
- Vallee, B.L.; Falchuk, K.H. The biochemical basis of zinc physiology. Physiol. Rev. 1993, 73, 79–118. [Google Scholar] [CrossRef]
- Corniola, R.S.; Tassabehji, N.M.; Hare, J.; Sharma, G.; Levenson, C.W. Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res. 2008, 1237, 52–61. [Google Scholar] [CrossRef]
- Wong, S.H.; Zhao, Y.; Schoene, N.W.; Han, C.T.; Shih, R.S.; Lei, K.Y. Zinc deficiency depresses p21 gene expression: Inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells. Am. J. Physiol. Cell Physiol. 2007, 292, C2175–C2184. [Google Scholar] [CrossRef] [Green Version]
- MacDonald, R.S. The role of zinc in growth and cell proliferation. J. Nutr. 2000, 130, 1500S–1508S. [Google Scholar] [CrossRef] [Green Version]
- Sharif, R.; Thomas, P.; Zalewski, P.; Graham, R.D.; Fenech, M. The effect of zinc sulphate and zinc carnosine on genome stability and cytotoxicity in the WIL2-NS human lymphoblastoid cell line. Mutat. Res. 2011, 720, 22–33. [Google Scholar] [CrossRef] [PubMed]
- Fukada, T.; Yamasaki, S.; Nishida, K.; Murakami, M.; Hirano, T. Zinc homeostasis and signaling in health and diseases: Zinc signaling. J. Biol. Inorg. Chem. 2011, 16, 1123–1134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelleher, S.L.; McCormick, N.H.; Velasquez, V.; Lopez, V. Zinc in specialized secretory tissues: Roles in the pancreas, prostate, and mammary gland. Adv. Nutr. 2011, 2, 101–111. [Google Scholar] [CrossRef] [PubMed]
- Murakami, M.; Hirano, T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 2008, 99, 1515–1522. [Google Scholar] [CrossRef]
- Hershfinkel, M. The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease. Int. J. Mol. Sci. 2018, 19, 439. [Google Scholar] [CrossRef] [Green Version]
- Maret, W. Zinc in Cellular Regulation: The Nature and Significance of “Zinc Signals”. Int. J. Mol. Sci. 2017, 18, 2285. [Google Scholar] [CrossRef] [Green Version]
- Yamasaki, S.; Sakata-Sogawa, K.; Hasegawa, A.; Suzuki, T.; Kabu, K.; Sato, E.; Kurosaki, T.; Yamashita, S.; Tokunaga, M.; Nishida, K.; et al. Zinc is a novel intracellular second messenger. J. Cell Biol. 2007, 177, 637–645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maret, W.; Krezel, A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol. Med. 2007, 13, 371–375. [Google Scholar] [CrossRef]
- Kashiv, Y.; Austin, J.R.; Lai, B.; Rose, V.; Vogt, S.; El-Muayed, M. Imaging trace element distributions in single organelles and subcellular features. Sci. Rep. 2016, 6, 21437. [Google Scholar] [CrossRef] [Green Version]
- Lu, Q.; Haragopal, H.; Slepchenko, K.G.; Stork, C.; Li, Y.V. Intracellular zinc distribution in mitochondria, ER and the Golgi apparatus. Int. J. Physiol. Pathophysiol. Pharm. 2016, 8, 35–43. [Google Scholar]
- Sensi, S.L.; Ton-That, D.; Weiss, J.H.; Rothe, A.; Gee, K.R. A new mitochondrial fluorescent zinc sensor. Cell Calcium. 2003, 34, 281–284. [Google Scholar] [CrossRef]
- Kambe, T.; Taylor, K.M.; Fu, D. Zinc transporters and their functional integration in mammalian cells. J. Biol. Chem. 2021, 296, 100320. [Google Scholar] [CrossRef] [PubMed]
- Maret, W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp. Gerontol. 2008, 43, 363–369. [Google Scholar] [CrossRef] [PubMed]
- Hara, T.; Takeda, T.A.; Takagishi, T.; Fukue, K.; Kambe, T.; Fukada, T. Physiological roles of zinc transporters: Molecular and genetic importance in zinc homeostasis. J. Physiol. Sci. 2017, 67, 283–301. [Google Scholar] [CrossRef] [PubMed]
- Alam, S.; Kelleher, S.L. Cellular mechanisms of zinc dysregulation: A perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutrients 2012, 4, 875–903. [Google Scholar] [CrossRef] [Green Version]
- Knoch, M.E.; Hartnett, K.A.; Hara, H.; Kandler, K.; Aizenman, E. Microglia induce neurotoxicity via intraneuronal Zn2+ release and a K+ current surge. Glia 2008, 56, 89–96. [Google Scholar] [CrossRef] [Green Version]
- McCord, M.C.; Aizenman, E. Convergent Ca2+ and Zn2+ signaling regulates apoptotic Kv2.1 K+ currents. Proc. Natl. Acad. Sci. USA 2013, 110, 13988–13993. [Google Scholar] [CrossRef] [Green Version]
- Taylor, K.M.; Hiscox, S.; Nicholson, R.I.; Hogstrand, C.; Kille, P. Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci. Signal. 2012, 5, ra11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Samet, J.M.; Dewar, B.J.; Wu, W.; Graves, L.M. Mechanisms of Zn2+-induced signal initiation through the epidermal growth factor receptor. Toxicol. Appl. Pharm. 2003, 191, 86–93. [Google Scholar] [CrossRef]
- Haase, H.; Maret, W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 2003, 291, 289–298. [Google Scholar] [CrossRef]
- Kim, Y.M.; Reed, W.; Wu, W.; Bromberg, P.A.; Graves, L.M.; Samet, J.M. Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290, L1028–L1035. [Google Scholar] [CrossRef] [Green Version]
- Bellomo, E.; Birla Singh, K.; Massarotti, A.; Hogstrand, C.; Maret, W. The metal face of protein tyrosine phosphatase 1B. Coord. Chem. Rev. 2016, 327–328, 70–83. [Google Scholar] [CrossRef] [Green Version]
- Podany, A.B.; Wright, J.; Lamendella, R.; Soybel, D.I.; Kelleher, S.L. ZnT2-Mediated Zinc Import Into Paneth Cell Granules Is Necessary for Coordinated Secretion and Paneth Cell Function in Mice. Cell Mol. Gastroenterol. Hepatol. 2016, 2, 369–383. [Google Scholar] [CrossRef] [Green Version]
- Hennigar, S.R.; Kelleher, S.L. Zinc networks: The cell-specific compartmentalization of zinc for specialized functions. Biol. Chem. 2012, 393, 565–578. [Google Scholar] [CrossRef] [Green Version]
- Cole, T.B.; Wenzel, H.J.; Kafer, K.E.; Schwartzkroin, P.A.; Palmiter, R.D. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc. Natl. Acad. Sci. USA 1999, 96, 1716–1721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nakashima-Kaneda, K.; Matsuda, A.; Mizuguchi, H.; Sasaki-Sakamoto, T.; Saito, H.; Ra, C.; Okayama, Y. Regulation of IgE-dependent zinc release from human mast cells. Int. Arch. Allergy Immunol. 2013, 161 (Suppl. S2), 44–51. [Google Scholar] [CrossRef]
- Gee, K.R.; Zhou, Z.L.; Qian, W.J.; Kennedy, R. Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. J. Am. Chem. Soc. 2002, 124, 776–778. [Google Scholar] [CrossRef]
- Chakraborty, M.; Asraf, H.; Sekler, I.; Hershfinkel, M. ZnR/GPR39 controls cell migration by orchestrating recruitment of KCC3 into protrusions, re-organization of actin and activation of MMP. Cell Calcium. 2021, 94, 102330. [Google Scholar] [CrossRef]
- Gore, A.; Moran, A.; Hershfinkel, M.; Sekler, I. Inhibitory mechanism of store-operated Ca2+ channels by zinc. J. Biol. Chem. 2004, 279, 11106–11111. [Google Scholar] [CrossRef] [Green Version]
- Krall, R.F.; Tzounopoulos, T.; Aizenman, E. The Function and Regulation of Zinc in the Brain. Neuroscience 2021, 457, 235–258. [Google Scholar] [CrossRef] [PubMed]
- Wu, W.; Silbajoris, R.A.; Whang, Y.E.; Graves, L.M.; Bromberg, P.A.; Samet, J.M. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289, L883–L889. [Google Scholar] [CrossRef] [PubMed]
- Samet, J.M.; Graves, L.M.; Quay, J.; Dailey, L.A.; Devlin, R.B.; Ghio, A.J.; Wu, W.; Bromberg, P.A.; Reed, W. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am. J. Physiol. 1998, 275, L551–L558. [Google Scholar] [CrossRef]
- Hansson, A. Extracellular zinc ions induces mitogen-activated protein kinase activity and protein tyrosine phosphorylation in bombesin-sensitive Swiss 3T3 fibroblasts. Arch. Biochem. Biophys. 1996, 328, 233–238. [Google Scholar] [CrossRef]
- Ryu, J.M.; Lee, M.Y.; Yun, S.P.; Han, H.J. Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: Involvement of PI3K/Akt, MAPKs, and mTOR. J. Cell Physiol. 2009, 218, 558–567. [Google Scholar] [CrossRef] [PubMed]
- Hershfinkel, M.; Moran, A.; Grossman, N.; Sekler, I. A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc. Natl. Acad. Sci. USA 2001, 98, 11749–11754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yasuda, S.; Miyazaki, T.; Munechika, K.; Yamashita, M.; Ikeda, Y.; Kamizono, A. Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum. J. Recept. Signal. Transduct. Res. 2007, 27, 235–246. [Google Scholar] [CrossRef] [PubMed]
- Besser, L.; Chorin, E.; Sekler, I.; Silverman, W.F.; Atkin, S.; Russell, J.T.; Hershfinkel, M. Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J. Neurosci. 2009, 29, 2890–2901. [Google Scholar] [CrossRef] [Green Version]
- Bostanci, Z.; Mack Jr, R.P.; Lee, S.; Soybel, D.I.; Kelleher, S.L. Paradoxical zinc toxicity and oxidative stress in the mammary gland during marginal dietary zinc deficiency. Reprod. Toxicol. 2015, 54, 84–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mutch, P.B.; Hurley, L.S. Mammary gland function and development: Effect of zinc deficiency in rat. Am. J. Physiol. 1980, 238, E26–E31. [Google Scholar] [CrossRef]
- Dempsey, C.; McCormick, N.H.; Croxford, T.P.; Seo, Y.A.; Grider, A.; Kelleher, S.L. Marginal maternal zinc deficiency in lactating mice reduces secretory capacity and alters milk composition. J. Nutr. 2012, 142, 655–660. [Google Scholar] [CrossRef] [Green Version]
- Rusidzé, M.; Adlanmérini, M.; Chantalat, E.; Raymond-Letron, I.; Cayre, S.; Arnal, J.F.; Deugnier, M.A.; Lenfant, F. Estrogen receptor-α signaling in post-natal mammary development and breast cancers. Cell Mol. Life Sci. 2021, 78, 5681–5705. [Google Scholar] [CrossRef]
- McCormick, N.H.; Hennigar, S.R.; Kiselyov, K.; Kelleher, S.L. The biology of zinc transport in mammary epithelial cells: Implications for mammary gland development, lactation, and involution. J. Mammary. Gland. Biol. Neoplasia. 2014, 19, 59–71. [Google Scholar] [CrossRef]
- Lee, S.; Kelleher, S.L. Molecular regulation of lactation: The complex and requisite roles for zinc. Arch. Biochem. Biophys. 2016, 611, 86–92. [Google Scholar] [CrossRef]
- McCormick, N.H.; Lee, S.; Hennigar, S.R.; Kelleher, S.L. ZnT4 (SLC30A4)-null (“lethal milk”) mice have defects in mammary gland secretion and hallmarks of precocious involution during lactation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 310, R33–R40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hennigar, S.R.; Seo, Y.A.; Sharma, S.; Soybel, D.I.; Kelleher, S.L. ZnT2 is a critical mediator of lysosomal-mediated cell death during early mammary gland involution. Sci. Rep. 2015, 5, 8033. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelleher, S.L.; Seo, Y.A.; Lopez, V. Mammary gland zinc metabolism: Regulation and dysregulation. Genes. Nutr. 2009, 4, 83–94. [Google Scholar] [CrossRef] [Green Version]
- Golan, Y.; Kambe, T.; Assaraf, Y.G. The role of the zinc transporter SLC30A2/ZnT2 in transient neonatal zinc deficiency. Metallomics 2017, 9, 1352–1366. [Google Scholar] [CrossRef]
- Bhatnagar, S.; Taneja, S. Zinc and cognitive development. Br. J. Nutr. 2001, 85 (Suppl. S2), S139–S145. [Google Scholar] [CrossRef] [Green Version]
- Krebs, N.F.; Miller, L.V.; Hambidge, K.M. Zinc deficiency in infants and children: A review of its complex and synergistic interactions. Paediatr. Int. Child. Health 2014, 34, 279–288. [Google Scholar] [CrossRef] [PubMed]
- Sian, L.; Mingyan, X.; Miller, L.V.; Tong, L.; Krebs, N.F.; Hambidge, K.M. Zinc absorption and intestinal losses of endogenous zinc in young Chinese women with marginal zinc intakes. Am. J. Clin. Nutr. 1996, 63, 348–353. [Google Scholar] [CrossRef] [PubMed]
- Krebs, N.F. Zinc transfer to the breastfed infant. J. Mammary. Gland. Biol. Neoplasia. 1999, 4, 259–268. [Google Scholar] [CrossRef] [PubMed]
- Ortega, R.M.; Andrés, P.; Martínez, R.M.; López-Sobaler, A.M.; Quintas, M.E. Zinc levels in maternal milk: The influence of nutritional status with respect to zinc during the third trimester of pregnancy. Eur. J. Clin. Nutr. 1997, 51, 253–258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dufner-Beattie, J.; Huang, Z.L.; Geiser, J.; Xu, W.; Andrews, G.K. Mouse ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc deficiency during pregnancy. Genesis 2006, 44, 239–251. [Google Scholar] [CrossRef] [PubMed]
- Kelleher, S.L.; Lopez, V.; Lönnerdal, B.; Dufner-Beattie, J.; Andrews, G.K. Zip3 (Slc39a3) functions in zinc reuptake from the alveolar lumen in lactating mammary gland. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297, R194–R201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelleher, S.L.; Velasquez, V.; Croxford, T.P.; McCormick, N.H.; Lopez, V.; MacDavid, J. Mapping the zinc-transporting system in mammary cells: Molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation. J. Cell Physiol. 2012, 227, 1761–1770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, S.; Hennigar, S.R.; Alam, S.; Nishida, K.; Kelleher, S.L. Essential Role for Zinc Transporter 2 (ZnT2)-mediated Zinc Transport in Mammary Gland Development and Function during Lactation. J. Biol. Chem. 2015, 290, 13064–13078. [Google Scholar] [CrossRef] [Green Version]
- Chowanadisai, W.; Lönnerdal, B.; Kelleher, S.L. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J. Biol. Chem. 2006, 281, 39699–39707. [Google Scholar] [CrossRef] [Green Version]
- Itsumura, N.; Kibihara, Y.; Fukue, K.; Miyata, A.; Fukushima, K.; Tamagawa-Mineoka, R.; Katoh, N.; Nishito, Y.; Ishida, R.; Narita, H.; et al. Novel mutations in SLC30A2 involved in the pathogenesis of transient neonatal zinc deficiency. Pediatr. Res. 2016, 80, 586–594. [Google Scholar] [CrossRef]
- Lee, S.; Rivera, O.C.; Kelleher, S.L. Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells. J. Biol. Chem. 2017, 292, 21598–21613. [Google Scholar] [CrossRef] [Green Version]
- Qian, L.; Lopez, V.; Seo, Y.A.; Kelleher, S.L. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells. Am. J. Physiol. Cell Physiol. 2009, 297, C369–C377. [Google Scholar] [CrossRef] [Green Version]
- Guo, L.; Lichten, L.A.; Ryu, M.S.; Liuzzi, J.P.; Wang, F.; Cousins, R.J. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc. Natl. Acad. Sci. USA 2010, 107, 2818–2823. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hennigar, S.R.; Kelleher, S.L. TNFα Post-Translationally Targets ZnT2 to Accumulate Zinc in Lysosomes. J. Cell Physiol. 2015, 230, 2345–2350. [Google Scholar] [CrossRef]
- Rivera, O.C.; Hennigar, S.R.; Kelleher, S.L. ZnT2 is critical for lysosome acidification and biogenesis during mammary gland involution. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2018, 315, R323–R335. [Google Scholar] [CrossRef]
- Fukunaka, A.; Suzuki, T.; Kurokawa, Y.; Yamazaki, T.; Fujiwara, N.; Ishihara, K.; Migaki, H.; Okumura, K.; Masuda, S.; Yamaguchi-Iwai, Y.; et al. Demonstration and characterization of the heterodimerization of ZnT5 and ZnT6 in the early secretory pathway. J. Biol. Chem. 2009, 284, 30798–30806. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fukunaka, A.; Kurokawa, Y.; Teranishi, F.; Sekler, I.; Oda, K.; Ackland, M.L.; Faundez, V.; Hiromura, M.; Masuda, S.; Nagao, M.; et al. Tissue nonspecific alkaline phosphatase is activated via a two-step mechanism by zinc transport complexes in the early secretory pathway. J. Biol. Chem. 2011, 286, 16363–16373. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kumar, L.; Michalczyk, A.; McKay, J.; Ford, D.; Kambe, T.; Hudek, L.; Varigios, G.; Taylor, P.E.; Ackland, M.L. Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk. Genes. Nutr. 2015, 10, 487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Prasad, A.S. Zinc: An overview. Nutrition 1995, 11, 93–99. [Google Scholar] [PubMed]
- Maares, M.; Haase, H. Zinc and immunity: An essential interrelation. Arch. Biochem. Biophys. 2016, 611, 58–65. [Google Scholar] [CrossRef]
- Kim, B.; Lee, W.W. Regulatory Role of Zinc in Immune Cell Signaling. Mol. Cells 2021, 44, 335–341. [Google Scholar] [CrossRef]
- Maywald, M.; Wang, F.; Rink, L. Zinc supplementation plays a crucial role in T helper 9 differentiation in allogeneic immune reactions and non-activated T cells. J. Trace Elem. Med. Biol. 2018, 50, 482–488. [Google Scholar] [CrossRef] [PubMed]
- Huang, L.; Kirschke, C.P.; Zhang, Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: A possible role in prostate cancer progression. Cancer Cell Int. 2006, 6, 10. [Google Scholar] [CrossRef] [Green Version]
- Costello, L.C.; Franklin, R.B. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch. Biochem. Biophys. 2016, 611, 100–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leitzmann, M.F.; Stampfer, M.J.; Wu, K.; Colditz, G.A.; Willett, W.C.; Giovannucci, E.L. Zinc supplement use and risk of prostate cancer. J. Natl. Cancer Inst. 2003, 95, 1004–1007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gonzalez, A.; Peters, U.; Lampe, J.W.; White, E. Zinc intake from supplements and diet and prostate cancer. Nutr. Cancer 2009, 61, 206–215. [Google Scholar] [CrossRef] [Green Version]
- Gumulec, J.; Masarik, M.; Adam, V.; Eckschlager, T.; Provaznik, I.; Kizek, R. Serum and tissue zinc in epithelial malignancies: A meta-analysis. PLoS ONE 2014, 9, e99790. [Google Scholar] [CrossRef] [PubMed]
- Lossow, K.; Schwarz, M.; Kipp, A.P. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox. Biol. 2021, 42, 101900. [Google Scholar] [CrossRef]
- Pavithra, V.; Sathisha, T.G.; Kasturi, K.; Mallika, D.S.; Amos, S.J.; Ragunatha, S. Serum levels of metal ions in female patients with breast cancer. J. Clin. Diagn. Res. 2015, 9, BC25–BC27. [Google Scholar] [CrossRef]
- Chandler, P.; Kochupurakkal, B.S.; Alam, S.; Richardson, A.L.; Soybel, D.I.; Kelleher, S.L. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer. Mol. Cancer 2016, 15, 2. [Google Scholar] [CrossRef] [Green Version]
- Farquharson, M.J.; Al-Ebraheem, A.; Geraki, K.; Leek, R.; Jubb, A.; Harris, A.L. Zinc presence in invasive ductal carcinoma of the breast and its correlation with oestrogen receptor status. Phys. Med. Biol. 2009, 54, 4213–4223. [Google Scholar] [CrossRef] [PubMed]
- Sullivan, K.V.; Moore, R.E.T.; Capper, M.S.; Schilling, K.; Goddard, K.; Ion, C.; Layton-Matthews, D.; Leybourne, M.I.; Coles, B.; Kreissig, K.; et al. Zinc stable isotope analysis reveals Zn dyshomeostasis in benign tumours, breast cancer, and adjacent histologically normal tissue. Metallomics 2021, 13, mfab027. [Google Scholar] [CrossRef]
- Larner, F.; Woodley, L.N.; Shousha, S.; Moyes, A.; Humphreys-Williams, E.; Strekopytov, S.; Halliday, A.N.; Rehkämper, M.; Coombes, R.C. Zinc isotopic compositions of breast cancer tissue. Metallomics 2015, 7, 112–117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Larner, F.; Shousha, S.; Coombes, R.C. Zinc isotopes: A novel approach to biomarkers of breast cancer? Biomark. Med. 2015, 9, 379–382. [Google Scholar] [CrossRef] [PubMed]
- Kiedrowski, L. Proton-dependent zinc release from intracellular ligands. J. Neurochem. 2014, 130, 87–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hara, H.; Aizenman, E. A molecular technique for detecting the liberation of intracellular zinc in cultured neurons. J. Neurosci. Methods 2004, 137, 175–180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nishito, Y.; Kambe, T. Zinc transporter 1 (ZNT1) expression on the cell surface is elaborately controlled by cellular zinc levels. J. Biol. Chem. 2019, 294, 15686–15697. [Google Scholar] [CrossRef]
- Bird, A.J.; McCall, K.; Kramer, M.; Blankman, E.; Winge, D.R.; Eide, D.J. Zinc fingers can act as Zn2+ sensors to regulate transcriptional activation domain function. Embo. J. 2003, 22, 5137–5146. [Google Scholar] [CrossRef] [Green Version]
- Ho, L.H.; Ruffin, R.E.; Murgia, C.; Li, L.; Krilis, S.A.; Zalewski, P.D. Labile zinc and zinc transporter ZnT4 in mast cell granules: Role in regulation of caspase activation and NF-kappaB translocation. J. Immunol. 2004, 172, 7750–7760. [Google Scholar] [CrossRef] [Green Version]
- Sharir, H.; Zinger, A.; Nevo, A.; Sekler, I.; Hershfinkel, M. Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J. Biol. Chem. 2010, 285, 26097–26106. [Google Scholar] [CrossRef] [Green Version]
- Singer, C.F.; Kronsteiner, N.; Marton, E.; Kubista, M.; Cullen, K.J.; Hirtenlehner, K.; Seifert, M.; Kubista, E. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast. Cancer Res. Treat. 2002, 72, 69–77. [Google Scholar] [CrossRef] [PubMed]
- Yin, X.F.; Jiang, L.B.; Ma, Y.Q.; Xu, J.; Gu, H.J.; Wu, X.H.; Li, X.L.; Dong, J. Decreased Zn2+ Influx Underlies the Protective Role of Hypoxia in Rat Nucleus Pulposus Cells. Biol. Trace Elem. Res. 2015, 168, 196–205. [Google Scholar] [PubMed]
- Azriel-Tamir, H.; Sharir, H.; Schwartz, B.; Hershfinkel, M. Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor. J. Biol. Chem. 2004, 279, 51804–51816. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohen, L.; Sekler, I.; Hershfinkel, M. The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon. Cell Death Dis. 2014, 5, e1307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lopez, V.; Foolad, F.; Kelleher, S.L. ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells. Cancer Lett. 2011, 304, 41–51. [Google Scholar] [CrossRef]
- Bostanci, Z.; Alam, S.; Soybel, D.I.; Kelleher, S.L. Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells. Exp. Cell Res. 2014, 321, 190–200. [Google Scholar] [CrossRef]
- Golan, Y.; Berman, B.; Assaraf, Y.G. Heterodimerization, altered subcellular localization, and function of multiple zinc transporters in viable cells using bimolecular fluorescence complementation. J. Biol. Chem. 2015, 290, 9050–9063. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Taylor, K.M.; Morgan, H.E.; Johnson, A.; Hadley, L.J.; Nicholson, R.I. Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. Biochem. J. 2003, 375, 51–59. [Google Scholar] [CrossRef]
- Taylor, K.M.; Morgan, H.E.; Smart, K.; Zahari, N.M.; Pumford, S.; Ellis, I.O.; Robertson, J.F.; Nicholson, R.I. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol. Med. 2007, 13, 396–406. [Google Scholar] [CrossRef] [PubMed]
- Taylor, K.M.; Nicholson, R.I. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim. Biophys Acta. 2003, 1611, 16–30. [Google Scholar] [CrossRef] [Green Version]
- Nimmanon, T.; Taylor, K.M. Posttranslational Mechanisms of Zinc Signaling. In Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, 1st ed.; Collins, J., Ed.; Academic Press: Amsterdam, Netherlands, 2017; pp. 273–281. [Google Scholar]
- Manning, D.L.; McClelland, R.A.; Gee, J.M.; Chan, C.M.; Green, C.D.; Blamey, R.W.; Nicholson, R.I. The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer. Eur. J. Cancer 1993, 29A, 1462–1468. [Google Scholar] [CrossRef]
- Tozlu, S.; Girault, I.; Vacher, S.; Vendrell, J.; Andrieu, C.; Spyratos, F.; Cohen, P.; Lidereau, R.; Bieche, I. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr. Relat. Cancer 2006, 13, 1109–1120. [Google Scholar] [CrossRef]
- Schneider, J.; Ruschhaupt, M.; Buness, A.; Asslaber, M.; Regitnig, P.; Zatloukal, K.; Schippinger, W.; Ploner, F.; Poustka, A.; Sültmann, H. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int. J. Cancer 2006, 119, 2974–2979. [Google Scholar] [CrossRef] [PubMed]
- Manning, D.L.; Robertson, J.F.; Ellis, I.O.; Elston, C.W.; McClelland, R.A.; Gee, J.M.; Jones, R.J.; Green, C.D.; Cannon, P.; Blamey, R.W.; et al. Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement. Eur. J. Cancer 1994, 30A, 675–678. [Google Scholar] [CrossRef]
- Yamashita, S.; Miyagi, C.; Fukada, T.; Kagara, N.; Che, Y.S.; Hirano, T. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 2004, 429, 298–302. [Google Scholar] [CrossRef]
- Hogstrand, C.; Kille, P.; Ackland, M.L.; Hiscox, S.; Taylor, K.M. A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3). Biochem. J. 2013, 455, 229–237. [Google Scholar] [CrossRef]
- Zhao, L.; Chen, W.; Taylor, K.M.; Cai, B.; Li, X. LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway. Biochem. Biophys. Res. Commun. 2007, 363, 82–88. [Google Scholar] [CrossRef]
- Taylor, K.M.; Morgan, H.E.; Johnson, A.; Nicholson, R.I. Structure-function analysis of HKE4, a member of the new LIV-1 subfamily of zinc transporters. Biochem. J. 2004, 377, 131–139. [Google Scholar] [CrossRef] [Green Version]
- Hogstrand, C.; Kille, P.; Nicholson, R.I.; Taylor, K.M. Zinc transporters and cancer: A potential role for ZIP7 as a hub for tyrosine kinase activation. Trends. Mol. Med. 2009, 15, 101–111. [Google Scholar] [CrossRef] [PubMed]
- Ziliotto, S.; Gee, J.M.W.; Ellis, I.O.; Green, A.R.; Finlay, P.; Gobbato, A.; Taylor, K.M. Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer. Metallomics 2019, 11, 1579–1592. [Google Scholar] [CrossRef] [Green Version]
- Taylor, K.M.; Vichova, P.; Jordan, N.; Hiscox, S.; Hendley, R.; Nicholson, R.I. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology 2008, 149, 4912–4920. [Google Scholar] [CrossRef] [Green Version]
- Xuhong, J.C.; Qi, X.W.; Zhang, Y.; Jiang, J. Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. Am. J. Cancer Res. 2019, 9, 2103–2119. [Google Scholar]
- Schlam, I.; Swain, S.M. HER2-positive breast cancer and tyrosine kinase inhibitors: The time is now. NPJ Breast Cancer 2021, 7, 56. [Google Scholar] [CrossRef]
- Chang, F.; Lee, J.T.; Navolanic, P.M.; Steelman, L.S.; Shelton, J.G.; Blalock, W.L.; Franklin, R.A.; McCubrey, J.A. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia 2003, 17, 590–603. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nimmanon, T.; Ziliotto, S.; Morris, S.; Flanagan, L.; Taylor, K.M. Phosphorylation of zinc channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling. Metallomics 2017, 9, 471–481. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Knowlden, J.M.; Hutcheson, I.R.; Barrow, D.; Gee, J.M.; Nicholson, R.I. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor. Endocrinology 2005, 146, 4609–4618. [Google Scholar] [CrossRef] [Green Version]
- Kagara, N.; Tanaka, N.; Noguchi, S.; Hirano, T. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci. 2007, 98, 692–697. [Google Scholar] [CrossRef] [PubMed]
- Taylor, K.M.; Muraina, I.A.; Brethour, D.; Schmitt-Ulms, G.; Nimmanon, T.; Ziliotto, S.; Kille, P.; Hogstrand, C. Zinc transporter ZIP10 forms a heteromer with ZIP6 which regulates embryonic development and cell migration. Biochem. J. 2016, 473, 2531–2544. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Takatani-Nakase, T.; Matsui, C.; Maeda, S.; Kawahara, S.; Takahashi, K. High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLoS ONE 2014, 9, e90136. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peairs, K.S.; Barone, B.B.; Snyder, C.F.; Yeh, H.C.; Stein, K.B.; Derr, R.L.; Brancati, F.L.; Wolff, A.C. Diabetes mellitus and breast cancer outcomes: A systematic review and meta-analysis. J. Clin. Oncol. 2011, 29, 40–46. [Google Scholar] [CrossRef] [PubMed]
- Nimmanon, T.; Ziliotto, S.; Ogle, O.; Burt, A.; Gee, J.M.W.; Andrews, G.K.; Kille, P.; Hogstrand, C.; Maret, W.; Taylor, K.M. The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis. Cell Mol. Life Sci. 2021, 78, 1781–1798. [Google Scholar] [CrossRef] [PubMed]
- Sunuwar, L.; Gilad, D.; Hershfinkel, M. The zinc sensing receptor, ZnR/GPR39, in health and disease. Front. Biosci. 2017, 22, 1469–1492. [Google Scholar]
- Popovics, P.; Stewart, A.J. GPR39: A Zn2+-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol. Life Sci. 2011, 68, 85–95. [Google Scholar] [CrossRef] [PubMed]
- Asraf, H.; Salomon, S.; Nevo, A.; Sekler, I.; Mayer, D.; Hershfinkel, M. The ZnR/GPR39 interacts with the CaSR to enhance signaling in prostate and salivary epithelia. J. Cell Physiol. 2014, 229, 868–877. [Google Scholar] [CrossRef]
- Dubi, N.; Gheber, L.; Fishman, D.; Sekler, I.; Hershfinkel, M. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells. Carcinogenesis 2008, 29, 1692–1700. [Google Scholar] [CrossRef] [Green Version]
- Storjohann, L.; Holst, B.; Schwartz, T.W. Molecular mechanism of Zn2+ agonism in the extracellular domain of GPR39. FEBS Lett. 2008, 582, 2583–2588. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mut, M.; Lule, S.; Demir, O.; Kurnaz, I.A.; Vural, I. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells. Int. J. Biochem. Cell Biol. 2012, 44, 302–310. [Google Scholar] [CrossRef] [PubMed]
- Sunuwar, L.; Medini, M.; Cohen, L.; Sekler, I.; Hershfinkel, M. The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis. Philos. Trans. R Soc. Lond B Biol. Sci. 2016, 371. [Google Scholar]
- Xie, F.; Liu, H.; Zhu, Y.H.; Qin, Y.R.; Dai, Y.; Zeng, T.; Chen, L.; Nie, C.; Tang, H.; Li, Y.; et al. Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 2011, 11, 86. [Google Scholar] [CrossRef] [Green Version]
- Ventura-Bixenshpaner, H.; Asraf, H.; Chakraborty, M.; Elkabets, M.; Sekler, I.; Taylor, K.M.; Hershfinkel, M. Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth. Sci. Rep. 2018, 8, 8119. [Google Scholar] [CrossRef] [PubMed]
- Ganay, T.; Asraf, H.; Aizenman, E.; Bogdanovic, M.; Sekler, I.; Hershfinkel, M. Regulation of neuronal pH by the metabotropic Zn2+-sensing Gq-coupled receptor, mZnR/GPR39. J. Neurochem. 2015, 135, 897–907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohen, L.; Azriel-Tamir, H.; Arotsker, N.; Sekler, I.; Hershfinkel, M. Zinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin. PLoS ONE 2012, 7, e35482. [Google Scholar] [CrossRef] [Green Version]
- Schneider, D.; Gerhardt, E.; Bock, J.; Müller, M.M.; Wolburg, H.; Lang, F.; Schulz, J.B. Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death Differ. 2004, 11, 760–770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Birkeland, E.S.; Koch, L.M.; Dechant, R. Another Consequence of the Warburg Effect? Metabolic Regulation of Na+/H+ Exchangers May Link Aerobic Glycolysis to Cell Growth. Front. Oncol. 2020, 10, 1561. [Google Scholar] [CrossRef] [PubMed]
- Harguindey, S.; Arranz, J.L.; Polo Orozco, J.D.; Rauch, C.; Fais, S.; Cardone, R.A.; Reshkin, S.J. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs—An integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. J. Transl. Med. 2013, 11, 282. [Google Scholar] [CrossRef] [Green Version]
- Wu, K.L.; Khan, S.; Lakhe-Reddy, S.; Jarad, G.; Mukherjee, A.; Obejero-Paz, C.A.; Konieczkowski, M.; Sedor, J.R.; Schelling, J.R. The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem. 2004, 279, 26280–26286. [Google Scholar] [CrossRef] [Green Version]
- Baumgartner, M.; Patel, H.; Barber, D.L. Na+/H+ exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am. J. Physiol. Cell Physiol. 2004, 287, C844–C850. [Google Scholar] [CrossRef] [Green Version]
- Chorin, E.; Vinograd, O.; Fleidervish, I.; Gilad, D.; Herrmann, S.; Sekler, I.; Aizenman, E.; Hershfinkel, M. Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor. J. Neurosci. 2011, 31, 12916–12926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gilad, D.; Shorer, S.; Ketzef, M.; Friedman, A.; Sekler, I.; Aizenman, E.; Hershfinkel, M. Homeostatic regulation of KCC2 activity by the zinc receptor mZnR/GPR39 during seizures. Neurobiol. Dis. 2015, 81, 4–13. [Google Scholar] [CrossRef] [Green Version]
- Rivera, C.; Voipio, J.; Payne, J.A.; Ruusuvuori, E.; Lahtinen, H.; Lamsa, K.; Pirvola, U.; Saarma, M.; Kaila, K. The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999, 397, 251–255. [Google Scholar] [CrossRef]
- Sunuwar, L.; Asraf, H.; Donowitz, M.; Sekler, I.; Hershfinkel, M. The Zn2+-sensing receptor, ZnR/GPR39, upregulates colonocytic Cl− absorption, via basolateral KCC1, and reduces fluid loss. Biochim. Biophys. Acta. Mol. Basis. Dis. 2017, 1863, 947–960. [Google Scholar] [CrossRef]
- Pedersen, S.F.; Hoffmann, E.K.; Novak, I. Cell volume regulation in epithelial physiology and cancer. Front. Physiol. 2013, 4, 233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mero, M.; Asraf, H.; Sekler, I.; Taylor, K.M.; Hershfinkel, M. ZnR/GPR39 upregulation of K(+)/Cl−-cotransporter 3 in tamoxifen resistant breast cancer cells. Cell Calcium. 2019, 81, 12–20. [Google Scholar] [CrossRef]
- Ali, S.; Coombes, R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2002, 2, 101–112. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Ma, H.; Yao, J. ERα, A Key Target for Cancer Therapy: A Review. Onco. Targets 2020, 13, 2183–2191. [Google Scholar] [CrossRef] [Green Version]
- Luque-Bolivar, A.; Pérez-Mora, E.; Villegas, V.E.; Rondón-Lagos, M. Resistance and Overcoming Resistance in Breast Cancer. Breast. Cancer 2020, 12, 211–229. [Google Scholar] [PubMed]
- da Silva, J.L.; Cardoso Nunes, N.C.; Izetti, P.; de Mesquita, G.G.; de Melo, A.C. Triple negative breast cancer: A thorough review of biomarkers. Crit. Rev. Oncol. Hematol. 2020, 145, 102855. [Google Scholar] [CrossRef]
- Gee, J.M.; Robertson, J.F.; Gutteridge, E.; Ellis, I.O.; Pinder, S.E.; Rubini, M.; Nicholson, R.I. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr. Relat. Cancer 2005, 12 (Suppl. S1), S99–S111. [Google Scholar] [CrossRef] [Green Version]
- Perry, R.R.; Kang, Y.; Greaves, B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann. Surg. Oncol. 1995, 2, 238–245. [Google Scholar] [CrossRef]
- Bursch, W.; Hochegger, K.; Torok, L.; Marian, B.; Ellinger, A.; Hermann, R.S. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell.Sci. 2000, 113, 1189–1198. [Google Scholar] [CrossRef]
- Nardone, A.; De Angelis, C.; Trivedi, M.V.; Osborne, C.K.; Schiff, R. The changing role of ER in endocrine resistance. Breast 2015, 24 (Suppl. S2), S60–S66. [Google Scholar] [CrossRef]
- Viedma-Rodríguez, R.; Baiza-Gutman, L.; Salamanca-Gómez, F.; Diaz-Zaragoza, M.; Martínez-Hernández, G.; Ruiz Esparza-Garrido, R.; Velázquez-Flores, M.A.; Arenas-Aranda, D. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol. Rep. 2014, 32, 3–15. [Google Scholar] [CrossRef] [Green Version]
- Hasson, S.P.; Rubinek, T.; Ryvo, L.; Wolf, I. Endocrine resistance in breast cancer: Focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway. Breast Care 2013, 8, 248–255. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983–3988. [Google Scholar] [CrossRef] [Green Version]
- Anurag, M.; Ellis, M.J.; Haricharan, S. DNA damage repair defects as a new class of endocrine treatment resistance driver. Oncotarget 2018, 9, 36252–36253. [Google Scholar] [CrossRef] [PubMed]
- Hanker, A.B.; Sudhan, D.R.; Arteaga, C.L. Overcoming Endocrine Resistance in Breast Cancer. Cancer Cell 2020, 37, 496–513. [Google Scholar] [CrossRef] [PubMed]
- Dent, R.; Trudeau, M.; Pritchard, K.I.; Hanna, W.M.; Kahn, H.K.; Sawka, C.A.; Lickley, L.A.; Rawlinson, E.; Sun, P.; Narod, S.A. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin. Cancer Res. 2007, 13, 4429–4434. [Google Scholar] [CrossRef] [Green Version]
- Mediratta, K.; El-Sahli, S.; D’Costa, V.; Wang, L. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 3529. [Google Scholar] [CrossRef]
- Sørlie, T.; Perou, C.M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M.B.; van de Rijn, M.; Jeffrey, S.S.; et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98, 10869–10874. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kübler, E.; Albrecht, H. Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: Potential for active targeting with engineered anti-cancer nanomedicines. Oncotarget 2018, 9, 24882–24897. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chakraborty, M.; Hershfinkel, M. Zinc Signaling in the Mammary Gland: For Better and for Worse. Biomedicines 2021, 9, 1204. https://doi.org/10.3390/biomedicines9091204
Chakraborty M, Hershfinkel M. Zinc Signaling in the Mammary Gland: For Better and for Worse. Biomedicines. 2021; 9(9):1204. https://doi.org/10.3390/biomedicines9091204
Chicago/Turabian StyleChakraborty, Moumita, and Michal Hershfinkel. 2021. "Zinc Signaling in the Mammary Gland: For Better and for Worse" Biomedicines 9, no. 9: 1204. https://doi.org/10.3390/biomedicines9091204